Related Experiment Videos
Diverticular disease treated with corticotrophin
The Journal of the Royal College of General Practitioners
|November 1, 1985
Summary
Tetracosactrin zinc effectively treats acute and chronic diverticulitis, reducing symptoms within 24 hours. This therapy more than halves illness duration without observed complications, outperforming rest and diet alone.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Diverticular disease, encompassing acute and chronic diverticulitis, presents inflammatory challenges.
- Traditional management involves rest and dietary adjustments.
Observation:
- Tetracosactrin (1 mg) administered intramuscularly was utilized for treating 100 episodes of diverticulitis since 1968.
- A comparative analysis included 50 episodes managed with conventional rest and dietary measures.
Findings:
- Tetracosactrin zinc demonstrated rapid abatement of pyrexia, swelling, and tenderness within 24 hours.
- Significant relief from pain and malaise was observed following tetracosactrin administration.
- The duration of clinical illness was reduced by over 50% in the tetracosactrin group.
- No complications were directly attributed to tetracosactrin therapy.
- Antibiotics did not influence outcomes in either treatment group.
Implications:
- Tetracosactrin offers a potentially effective and safe therapeutic option for acute and chronic diverticulitis.
- This treatment may significantly shorten recovery time compared to conventional methods.
- Further research into tetracosactrin's mechanism in diverticulitis is warranted.